BALTIMORE, MD-Lupin Pharmaceutics is renewing and expanding its space at Harborplace Tower, an office building at 111 S. Calvert St., owned by General Growth Properties. Lupin is taking 34,432 square feet in the building on two full floors.
Tim Jackson with Cushman & Wakefield represented GGP. Lupin Pharmaceuticals was represented by Bruce Matthai with Cassidy Turley.
"As part of the Baltimore community, we are very fortunate that Lupin Pharmaceuticals has selected Baltimore as the location for its U.S. headquarters and as a representative for 111 S. Calvert, we are highly pleased to be able to play a role in complementing their growth in our market," said Jackson, in a prepared statement.
Earlier this year, AAC HP Realty LLC of New York City, an affiliate of investment firm Ashkenazy Acquisition Corp., purchased the Harborplace waterfront shopping center for $98.5 million. General Growth Properties owned that property as well.
© Touchpoint Markets, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more inforrmation visit Asset & Logo Licensing.
Erika Morphy
Erika Morphy has been writing about commercial real estate at GlobeSt.com for more than ten years, covering the capital markets, the Mid-Atlantic region and national topics. She's a nerd so favorite examples of the former include accounting standards, Basel III and what Congress is brewing.
